CIK 0001000694
- Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222816046
- Phone
- +1 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-01 | Casey Mark J EVP, Chief Legal Officer | Option exercise | +4,000 | 33,187 | ||
| 2025-03-01 | Casey Mark J EVP, Chief Legal Officer | Shares withheld for taxes | −1,214 | $8.33 | $10K | 31,973 |
| 2025-03-01 | Casey Mark J EVP, Chief Legal Officer | Option exercise · Restricted Stock Units | −4,000 | 8,000 | ||
| 2025-03-01 | Kelly James Patrick EVP, CFO and Treasurer | Option exercise | +58,667 | 91,269 | ||
| 2025-03-01 | Kelly James Patrick EVP, CFO and Treasurer | Shares withheld for taxes | −28,337 | $8.33 | $236K | 62,932 |
| 2025-03-01 | Kelly James Patrick EVP, CFO and Treasurer | Option exercise · Restricted Stock Units | −58,667 | 117,333 | ||
| 2025-03-01 | Jacobs John C President and CEO | Option exercise | +83,334 | 175,183 | ||
| 2025-03-01 | Jacobs John C President and CEO | Shares withheld for taxes | −38,451 | $8.33 | $320K | 136,732 |
| 2025-03-01 | Jacobs John C President and CEO | Option exercise · Restricted Stock Units | −83,334 | 166,666 | ||
| 2025-03-01 | O'Hara Elaine EVP, Chief Strategy Officer | Option exercise | +19,600 | 33,825 | ||
| 2025-03-01 | O'Hara Elaine EVP, Chief Strategy Officer | Option exercise | +40,000 | 73,825 | ||
| 2025-03-01 | O'Hara Elaine EVP, Chief Strategy Officer | Shares withheld for taxes | −5,375 | $8.33 | $45K | 68,450 |
| 2025-03-01 | O'Hara Elaine EVP, Chief Strategy Officer | Shares withheld for taxes | −10,969 | $8.33 | $91K | 57,481 |
| 2025-03-01 | O'Hara Elaine EVP, Chief Strategy Officer | Option exercise · Restricted Stock Units | −19,600 | 19,600 | ||
| 2025-03-01 | O'Hara Elaine EVP, Chief Strategy Officer | Option exercise · Restricted Stock Units | −40,000 | 80,000 | ||
| 2025-01-23 | Jacobs John C President and CEO | Option exercise | +83,196 | 130,722 | ||
| 2025-01-23 | Jacobs John C President and CEO | Shares withheld for taxes | −38,873 | $9.55 | $371K | 91,849 |
| 2025-01-23 | Jacobs John C President and CEO | Option exercise · Restricted Stock Units | −83,196 | 83,197 | ||
| 2024-12-31 | Alton Gregg H Director | Grant or award | +1,982 | $8.61 | $17K | 18,385 |
| 2024-12-31 | MCGLYNN MARGARET G Director | Grant or award | +1,178 | $8.61 | $10K | 15,168 |
Page 8 of 14 · 279 trades